Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group (Q78247436)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

C Villaran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

S J O'Neill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A Helbling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

J A van Noord

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

T H Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A G Chuchalin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

S J Langley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

K A Gunawardena

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

S Suskovic

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M Laurenzi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

J Jasan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

J Menten

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

J A Leff

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Allergy and Clinical Immunology

12 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

3 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

547-553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

A comparison of the asthmatic response to methacholine and exercise

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Rapid Onset of Tolerance to the Bronchoprotective Effect of Salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

The effect of regular inhaled albuterol on exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Standardization of Spirometry, 1994 Update. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4–receptor antagonist cinalukast☆☆☆★

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

Salmeterol tachyphylaxis in steroid treated asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970322-2

7 January 2021

10.1016/S0091-6749(99)70322-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482826%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference